Toll-like receptors and adaptor molecules in liver disease: update. - Wikidata - awgldk - TriplyDB

Toll-like receptors and adaptor molecules in liver disease: update.

Toll-like receptors and adaptor molecules in liver disease: update.

http://www.wikidata.org/entity/Q37174620

about

Liver immunology and its role in inflammation and homeostasis The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of Myofibroblasts Crosstalk between innate and adaptive immunity in hepatitis B virus infection Alcohol's Effect on Host Defense Assessing cardiovascular risk in hepatitis C: An unmet need Emerging role of Toll-like receptor 4 in hepatocellular carcinoma Regulation of hepatic innate immunity by hepatitis C virus Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease Signal transductions and nonalcoholic fatty liver: a mini-review Innate immune responses in hepatitis C virus infection Trypanosoma cruzi infection is a potent risk factor for non-alcoholic steatohepatitis enhancing local and systemic inflammation associated with strong oxidative stress and metabolic disorders Dynamic imaging of experimental Leishmania donovani-induced hepatic granulomas detects Kupffer cell-restricted antigen presentation to antigen-specific CD8 T cells TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver Emerging role of microRNAs in liver diseases The role of inflammation in cholestasis: clinical and basic aspects Toll-like receptors in pathophysiology of liver diseases Molecular Pathogenesis of NASH Vitamin D: a new player in non-alcoholic fatty liver disease?NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis Temporal expression of chemokines dictates the hepatic inflammatory infiltrate in a murine model of schistosomiasis Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients Promising therapies for treatment of nonalcoholic steatohepatitis.The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis.Development of a spontaneous liver disease resembling autoimmune hepatitis in mice lacking tyro3, axl and mer receptor tyrosine kinases Effect of toll-like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma.Networks inferred from biochemical data reveal profound differences in toll-like receptor and inflammatory signaling between normal and transformed hepatocytes.Role of NADPH oxidases in liver fibrosis.Role of serotonin in fatty acid-induced non-alcoholic fatty liver disease in mice.Tickling the TLR7 to cure viral hepatitis.Importance of TLR2 on hepatic immune and non-immune cells to attenuate the strong inflammatory liver response during Trypanosoma cruzi acute infection Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation.Biological functions of exosomes in the liver in health and disease.Blood fluke exploitation of non-cognate CD4+ T cell help to facilitate parasite development.A microarray analysis of early activated pathways in concanavalin A-induced hepatitis.The Impact of Sterile Inflammation in Acute Liver Injury.Steatosis and steatohepatitis: complex disorders.Ron receptor-dependent gene regulation in a mouse model of endotoxin-induced acute liver failure Inhibitory effect of tanshinone IIA on rat hepatic stellate cells

P2860

Q26750478-9CE6DF9B-57FD-43ED-A61E-F0A303ACD39A Q26766479-8A52BE08-A42C-4EE5-9781-46606215268A Q26771142-6598D102-F6C2-4E0B-8103-8B2B7FCD9569 Q26773204-03D2F696-5BAD-4363-B64C-0B77CF5651EC Q26784258-97CA9CE7-5089-42D6-B169-B8D90926F746 Q26824613-B4058F8B-D392-41C6-A0B8-86C0FA5B5C3B Q26824743-FECC1CED-66C5-43C0-B4EE-C62843FB912B Q26826919-61A148EE-E3F2-4747-AD22-22A09CCBA678 Q26828547-09F7D409-F19F-49FF-8398-94AF83B20E6B Q26852498-596CA253-48F7-488E-9A0F-502D09696958 Q26991757-7B62A6D6-72B1-420A-93B2-9DE4F1136D28 Q27023055-86E88574-703C-4C23-9F3F-E1FA1435EEAD Q27304622-4E139186-0D95-4A23-8FD0-9FE01A4D4C20 Q27315334-5D00179B-C1FD-4AF0-84DD-01F43AAB19C9 Q27334969-185B5C0A-B94C-4E63-91CA-D0F7ED70DDFB Q27490492-DD5E70EF-2FCD-4873-B313-51135E61569C Q27694662-A740EEC4-E464-4DBB-9EF3-26DF2276331E Q28070077-3DFAFC97-6866-4F44-8135-0555F30223D5 Q28071265-E584C158-85CB-4388-B73B-5FE79B95521F Q28081391-262E576C-8D42-4D04-851B-7D23739B357B Q28384956-898AFD4F-00F4-4867-9066-01BC7A814A8E Q28472805-8577EBE8-D095-4475-B19D-9BE15235D504 Q28748743-AB90E926-2BAD-4299-B210-68495D4A3840 Q30248578-E8AA01AE-3BCA-4DFE-9A07-0DB76AB6327F Q30382395-A15C1AE9-D55D-4CF4-B6FE-22F7E7AC2EEE Q31121156-9737E290-3121-49B0-8F67-5643AFC7EF49 Q31170767-12BDBAD6-3081-41CF-A39C-0A93A927744C Q33575787-802800BD-0BEA-4468-923D-DDACDA5F00D7 Q33632736-0AAF01B7-B59B-459C-9AA7-01FB39F20BDB Q33645106-EF91B2CF-954C-4402-AE2F-5603F72E4268 Q33690260-B102F15F-D5A9-42DA-8686-B19BA86AF01A Q33745191-1E0B62D6-3358-4785-A84F-093C4BD3FEBB Q33755829-30B13BAC-ABFA-40ED-85E1-0241E9770636 Q33807950-5E748319-20EF-4B5A-BD68-06414436897E Q33818866-D29D383F-C1F2-431E-ADCE-41FEA57991AE Q33834632-C7B8AA88-E165-40CE-B54C-551FCC1561F0 Q33847610-2C0E7DFA-943F-410C-B961-315481A94C00 Q33907632-B85865FB-B4E7-42A5-AF92-51B740B3CC99 Q33916039-37052180-2009-42F5-BC98-8AE1DE8D6ED1 Q33975195-0E294A28-53E2-4A26-B14F-3B68D2D83F1F

P2860

Toll-like receptors and adaptor molecules in liver disease: update.

http://www.wikidata.org/entity/Q37174620

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Toll-like receptors and adaptor molecules in liver disease: update.

@en

Toll-like receptors and adaptor molecules in liver disease: update.

@nl

type

label

Toll-like receptors and adaptor molecules in liver disease: update.

@en

Toll-like receptors and adaptor molecules in liver disease: update.

@nl

prefLabel

Toll-like receptors and adaptor molecules in liver disease: update.

@en

Toll-like receptors and adaptor molecules in liver disease: update.

@nl

P1433

Q37174620-31959B37-FEEB-4C84-9304-A52D09A916DE

P1476

Q37174620-8D643E71-CB5B-4DA3-BE66-CBFD3B9C673E

P2093

Q37174620-E97CB788-3A8B-4077-B0E2-B2C89581D512

P2860

Q37174620-221EB745-EC9F-4E88-B927-7FBF7D508D0B

Q37174620-248FBA3F-E93B-4673-8F1B-372A48634E85

Q37174620-2A5A0356-ADFF-4949-9200-8C4FFC06646C

Q37174620-34A5BB46-3FFF-4193-BAD2-219F5F92363A

Q37174620-6A18F223-78EB-4E91-B555-EA910ABDD331

Q37174620-77D9644B-D622-426C-A348-B45F6244E748

Q37174620-A0167BB8-550B-4D36-8FCF-E2F718F23E8A

Q37174620-AC74616F-ACB2-4C0E-A776-0F2371CDCF25

Q37174620-D556829B-CED3-42E8-8560-3FEADE788078

Q37174620-E3CB6517-F2D3-4619-9A45-934F25CAEFAA

P304

Q37174620-6CA38BF3-D516-4ECB-8222-C7CAE5DD5E46

P31

Q37174620-3102BAD4-A9B7-411F-A518-818E6E5B4CCC

P356

Q37174620-BFE28089-DE21-4C75-959C-63B4C2999C9C

P407

Q37174620-47993877-17D2-4964-9C98-EC2E3181E49A

P433

Q37174620-9CC3580B-2186-4714-8D9C-1C9D9A2C7D5E

P478

Q37174620-BEAE2CC2-D7AF-4AC9-A054-664385A3061C

P50

Q37174620-E849BA64-F01B-4BA0-B2C1-13B92D9AA7DD

P577

Q37174620-48B53115-42A3-430B-A071-B791E1E1C952

P5875

Q37174620-7FDE6250-6DC8-4D5F-8562-6B3B60AAAC51

P698

Q37174620-DD591F35-5EB2-4A1E-B9F7-4F558AB2DD6F

P921

Q37174620-09558D01-EA75-4D13-98E6-A068BED955AC

P356

P1433

P1476

Toll-like receptors and adaptor molecules in liver disease: update.

@en

P2093

Ekihiro Seki

http://www.w3.org/2001/XMLSchema#string

P2860

Apoptosis induced by the toll-like receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif

Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity

Hepatocyte-specific inhibition of NF-kappaB leads to apoptosis after TNF treatment, but not after partial hepatectomy.

TLR ligand-dependent activation of naive CD4 T cells by plasmacytoid dendritic cells is impaired in hepatitis C virus infection.

Reduced early alcohol-induced liver injury in CD14-deficient mice.

Role of lipopolysaccharide-binding protein in early alcohol-induced liver injury in mice.

MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria: no role for either in macrophage listericidal activity.

Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway.

Toll-like receptor 4 dependence of innate and adaptive immunity to Salmonella: importance of the Kupffer cell network.

P304

322-335

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.22306

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P50

David A. Brenner

P577

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5343787

http://www.w3.org/2001/XMLSchema#string

P698

18506843

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor